{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:37Z","timestamp":1760060977015,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jsat.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T00:45:56Z","timestamp":1434501956000},"page":"90-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia"],"prefix":"10.1016","volume":"58","author":[{"given":"Kerryn","family":"Butler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Alati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.jsat.2015.06.008_bb0005","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/cid\/cit305","article-title":"Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: The ETHOS Study","volume":"57","author":"Alavi","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2015.06.008_bb0010","series-title":"Drug Treatment Series no 23. Cat. No. HSE 147","article-title":"National opioid pharmacotherapy statistics 2013","author":"Australian Institute of Health and Welfare","year":"2014"},{"issue":"93","key":"10.1016\/j.jsat.2015.06.008_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2015.06.008_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/09540120701426524","article-title":"Experience of hepatitis C testing among injecting drug users in Sydney, Australia","volume":"20","author":"Day","year":"2008","journal-title":"AIDS Care"},{"year":"2014","series-title":"Fourth National Hepatitis C Strategy 2014\u20132017","author":"Department of Health","key":"10.1016\/j.jsat.2015.06.008_bb0035"},{"issue":"Supplement 5","key":"10.1016\/j.jsat.2015.06.008_bb0040","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1086\/427446","article-title":"Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia","volume":"40","author":"Doab","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1016\/j.jsat.2015.06.008_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2015.06.008_bb0065","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/cid\/cit264","article-title":"Moving the agenda forward: The prevention and management of hepatitis C virus infection among people who inject drugs","volume":"57","author":"Grebely","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2015.06.008_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","article-title":"Barriers associated with the treatment of hepatitis C virus infection among illicit drug users","volume":"93","author":"Grebely","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2015.06.008_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2893.2010.01279.x","article-title":"Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents","volume":"18","author":"Grebely","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"issue":"5","key":"10.1016\/j.jsat.2015.06.008_bb0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01080.x","article-title":"Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents","volume":"16","author":"Grebely","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"year":"2013","series-title":"SPSS for Windows version 22.0 (Version 22.0)","author":"IBM","key":"10.1016\/j.jsat.2015.06.008_bb0075"},{"key":"10.1016\/j.jsat.2015.06.008_bb0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2011.08.005","article-title":"The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature","volume":"23","author":"Islam","year":"2012","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2015.06.008_bb0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jsat.2012.07.007","article-title":"Linkage into specialist hepatitis C treatment services of injecting drug users attending a harm minimisation based healthcare centre","volume":"43","author":"Islam","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"year":"2014","series-title":"Australian Needle and Syringe Program Survey National Data Report 2009\u20132013","author":"Iversen","key":"10.1016\/j.jsat.2015.06.008_bb0100"},{"issue":"3","key":"10.1016\/j.jsat.2015.06.008_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jvh.12129","article-title":"Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999\u20132011","volume":"21","author":"Iversen","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"1","key":"10.1016\/j.jsat.2015.06.008_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2036.2008.03872.x","article-title":"Clinical trial: A primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C","volume":"29","author":"Jack","year":"2009","journal-title":"Alimentary Pharmacology and Therapeutics"},{"year":"2014","series-title":"HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2014","author":"Kirby Institute","key":"10.1016\/j.jsat.2015.06.008_bb0070"},{"key":"10.1016\/j.jsat.2015.06.008_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2014.12.027","article-title":"Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study","volume":"148","author":"Larney","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.06.008_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2013","journal-title":"The International Journal on Drug Policy"},{"issue":"10","key":"10.1016\/j.jsat.2015.06.008_bb0135","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2105\/AJPH.2013.301458","article-title":"A randomized trial of a hepatitis care coordination model in methadone maintenance treatment","volume":"103","author":"Masson","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"9791","key":"10.1016\/j.jsat.2015.06.008_bb1000","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.jsat.2015.06.008_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1465-3362.2012.00502.x","article-title":"Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs","volume":"32","author":"O'Keefe","year":"2013","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2015.06.008_bb0155","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/add.12392","article-title":"On behalf of the ETHOS Study Group. 'Not just Methadone Tracy': Transformations in service-user identify following the introduction of hepatitis C treatment into Australian opiate substitution settings","volume":"109","author":"Rance","year":"2013","journal-title":"Addiction"},{"issue":"s1","key":"10.1016\/j.jsat.2015.06.008_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm","volume":"21","author":"Razavi","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"2","key":"10.1016\/j.jsat.2015.06.008_bb0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1753-6405.12173","article-title":"Hepatitis C testing and status among opioid substitution treatment clients in New South Wales","volume":"38","author":"Shand","year":"2014","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1016\/j.jsat.2015.06.008_bb0170","series-title":"Australian Drug Trend Series No. 109","article-title":"Australian Drug Trends 2013. Findings from the Illicit Drug Reporting System (IDRS)","author":"Stafford","year":"2014"},{"issue":"15","key":"10.1016\/j.jsat.2015.06.008_bb0180","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"issue":"21","key":"10.1016\/j.jsat.2015.06.008_bb0185","first-page":"560","article-title":"Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: Insights from the ETHOS study","volume":"2014","author":"Treloar","year":"2013","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"10.1016\/j.jsat.2015.06.008_bb0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"The Medical Journal of Australia"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:42:31Z","timestamp":1760038951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547215001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"alternative-id":["S0740547215001440"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2015.06.008","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}